Including launch of two new tests to differentiate between COVID-19 and common winter viruses, and between COVID-19 variants

Paris, France and Camberley, UK - 30 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&D update.

http://novacyt.com/wp-content/uploads/2021/09/Novacyt-RD-update.pdf

Attachments

  • Original document
  • Permalink

Disclaimer

Novacyt SA published this content on 30 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 September 2021 06:11:10 UTC.